Motilal Oswal
Sun Pharma (SUNP) delivered better-than-expected 1QFY25 earnings, led by an improved segmental mix and lower RM costs.
Sun Pharmaceutical Industries Ltd. is trading at high day volume of 7.3M.
More from Sun Pharmaceutical Industries Ltd.
Recommended